Quarter For Amneal Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Public Employees Retirement System of Ohio Sells 10,685 Shares of Amneal Pharmaceuticals, Inc (NASDAQ:AMRX)

Public Employees Retirement System of Ohio Sells 10,685 Shares of Amneal Pharmaceuticals, Inc (NASDAQ:AMRX)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesPiper sandlerMillennium managementAmneal pharmaceuticals stockMorgan stanleyNews ratings for amneal pharmaceuticals dailyGoldman sachs groupQuarter for amneal pharmaceuticalsAmneal pharmaceuticals incNorges bankAmneal pharmaceuticalsVanguard group incPublic employees retirement systemFree reportEmployees retirement systemCapital management

Public Employees Retirement System of Ohio Has $165,000 Holdings in Amneal Pharmaceuticals, Inc (NASDAQ:AMRX)

Public Employees Retirement System of Ohio Has $165,000 Holdings in Amneal Pharmaceuticals, Inc (NASDAQ:AMRX)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesPiper sandlerGoldman sachs groupVoloridge investment managementQuarter for amneal pharmaceuticalsAmneal pharmaceuticals incAmneal pharmaceuticalsVanguard group incAmneal pharmaceuticals profileNantahala capital managementAmneal pharmaceuticals stockGroup plcBarclays plcNews ratings for amneal pharmaceuticals dailyPublic employees retirement systemFree report

Connor Clark & Lunn Investment Management Ltd Boosts Stake in Amneal Pharmaceuticals, Inc (NASDAQ:AMRX)

Connor Clark & Lunn Investment Management Ltd. raised its position in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Free Report) by 27.8% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 492,304 shares of the company’s stock after buying an additional 107,090 shares […]

Blackrock incConnor clark lunn investment management ltdAmneal pharmaceuticalsMetlife investment managementPanagora asset management incExchange commissionQuarter for amneal pharmaceuticalsNews ratings for amneal pharmaceuticals dailyYork mellon corpAmneal pharmaceuticals incAmneal pharmaceuticals profileAmneal pharmaceuticals price performanceSwiss national bankConnor clarkLunn investment managementFree report

Tejara Capital Ltd Purchases New Stake in Amneal Pharmaceuticals, Inc (NASDAQ:AMRX)

Tejara Capital Ltd purchased a new stake in shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 96,672 shares of the company’s stock, valued at approximately $408,000. A number of […]

Tejara capital ltdAmneal pharmaceuticals stock performanceExchange commissionAmneal pharmaceuticals incJump financialCharles schwab investment management incAmneal pharmaceuticals company profileQuarter for amneal pharmaceuticalsNews ratings for amneal pharmaceuticals dailyAmneal pharmaceuticalsFree reportSchwab investment managementVisit holdingschannelAmneal pharmaceuticals dailyNasdaq amrxSec filings

Amneal Pharmaceuticals, Inc (NYSE:AMRX) Stock Holdings Trimmed by Eversept Partners LP

Eversept Partners LP lowered its position in shares of Amneal Pharmaceuticals, Inc. (NYSE:AMRX – Get Rating) by 82.3% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 830,960 shares of the company’s stock after selling 3,859,852 shares during the quarter. Eversept Partners LP owned […]

Piper sandlerYork mellon corpAmneal pharmaceuticalsQuarter for amneal pharmaceuticalsNews ratings for amneal pharmaceuticals dailyCharles schwab investment management incSwiss national bankAmneal pharmaceuticals company profileAmneal pharmaceuticals incSecurities exchange commissionAmneal pharmaceuticals stock performanceSei investments coEversept partnersGet ratingNew york mellon corpSchwab investment management